SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer Meeting Abstract


Authors: Vergote, I.; Perez-Fidalgo, J. A.; Hamilton, E. P.; Van Gorp, T.; Valabrega, G.; Laenen, A.; Oza, A. M.; Levy, T.; Cibula, D.; Sehouli, J.; Guerra, E.; Chon, H. S.; Bergamini, A.; Romero, I.; Michel, D.; Shah, J. J.; Monk, B. J.; Slomovitz, B. M.; Mirza, M. R.; Makker, V.
Abstract Title: SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120306331
DOI: 10.1200/JCO.2021.39.15_suppl.TPS5610
PROVIDER: wos
Notes: Meeting Abstract: TPS5610 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    263 Makker